Table 1.
Patient demographic and clinical characteristics of JLD and control groups at baseline
| Characteristics | JLD group (n = 32) | Control group (n = 29) | t | P |
|---|---|---|---|---|
| Age (years) | 47.1 ± 7.1 | 49.9 ± 7.2 | −1.527 | 0.132 |
| Male | 17 (53.1) | 14 (48.3) | 0.143 | 0.800 |
| Weight (kg) | 61.7 ± 9.0 | 62.7 ± 8.2 | −0.453 | 0.652 |
| BMI (kg/m2) | 22.9 ± 2.5 | 23.6 ± 2.7 | 0.945 | 0.280 |
| Waist (cm) | 83.4 ± 9.1 | 81.5 ± 5.4 | 0.960 | 0.341 |
| Waist/hip ratio | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.957 | 0.343 |
| FPG (mmol/L) | 6.2 ± 0.5 | 6.3 ± 0.6 | −0.956 | 0.343 |
| 2-h PG (mmol/L) | 8.5 ± 2.1 | 9.4 ± 1.6 | −1.841 | 0.071 |
| HbA1c (%) | 6.5 ± 0.7 | 6.5 ± 0.5 | 0.007 | 0.994 |
| Fasting insulin (μU/ml) | 9.2 (7.0, 15.3) | 9.0 (8.1, 10.7) | −0.159 | 0.874 |
| HOMA-IR | 2.4 (2.0, 4.0) | 2.5 (2.1, 3.0) | −0.116 | 0.908 |
| Triglycerides (mg/L) | 15.3 ± 7.8 | 15.4 ± 7.9 | −0.026 | 0.979 |
| Total cholesterol (mg/L) | 56.1 ± 10.5 | 55.5 ± 9.1 | 0.244 | 0.808 |
| HDL-C (mg/L) | 13.5 ± 3.1 | 14.2 ± 2.7 | −0.905 | 0.369 |
| LDL-C (mg/L) | 33.8 ± 6.2 | 32.4 ± 8.3 | 0.740 | 0.462 |
Data are shown as mean ± SD, n (%), or median (Q1, Q3). The difference between groups was nonsignificant at the level P>0.05 at baseline tested by Student’s t-test or Chi-square test. BMI: Body mass index; FPG: Fasting plasma glucose; 2-h PG: 2-h plasma glucose; HbA1c: Glycated hemoglobin A1c; HOMA-IR: Insulin resistance index of homeostasis model assessment; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; JLD: Jinlida; SD: Standard deviation.